Literature DB >> 9310600

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

T A McDonagh1, C E Morrison, A Lawrence, I Ford, H Tunstall-Pedoe, J J McMurray, H J Dargie.   

Abstract

BACKGROUND: In most previous epidemiological studies on the prevalence of chronic heart failure (CHF) the disorder has been defined on clinical criteria. In a cross-sectional survey of 2000 men and women aged 25-74, randomly sampled from one geographical area, we assessed left-ventricular systolic function by echocardiography.
METHODS: 1640 (83%) of those invited took part. They completed a questionnaire on current medication, history, and symptoms of breathlessness. Blood pressure was measured and electrocardiography (ECG) and echocardiography were done. Left-ventricular ejection fraction was measurable in 1467 (89.5%) participants by the biplane Simpson's rate method.
FINDINGS: The mean left-ventricular ejection fraction was 47.3%. The prevalence of definite left-ventricular systolic dysfunction (defined as a left-ventricular ejection fraction < or = 30%) was 2.9% overall (43 participants); it increased with age and was higher in men than in women (4.0 vs 2.0%). The left-ventricular systolic dysfunction was symptomatic in 1.5% of participants and asymptomatic in 1.4%, 83% of participants with left-ventricular systolic dysfunction had evidence of ischaemic heart disease (IHD) from history or ECG criteria compared with 21% of those without this abnormality (p < 0.001). Hypertension was also more common in those with left-ventricular systolic dysfunction (72 vs 38%, p < 0.001), but there was no difference between those with and without left-ventricular systolic dysfunction in the rate of hypertension without IHD.
INTERPRETATION: Left-ventricular systolic dysfunction was at least twice as common as symptomatic heart failure defined by clinical criteria. The main risk factors are IHD and hypertension in the presence of IHD; screening of such high-risk groups for left-ventricular systolic dysfunction should be considered.

Entities:  

Mesh:

Year:  1997        PMID: 9310600     DOI: 10.1016/S0140-6736(97)03033-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  109 in total

1.  The scale of heart failure: diagnosis and management issues for primary care.

Authors:  F D Hobbs
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 2.  Epidemiology, aetiology, and prognosis of heart failure.

Authors:  J J McMurray; S Stewart
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

Review 3.  Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

Authors:  S Talwar; P F Downie; L L Ng; I B Squire
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

4.  Can heart failure be diagnosed in primary care?

Authors:  R Hobbs
Journal:  BMJ       Date:  2000-07-22

5.  The barriers to effective management of heart failure in general practice.

Authors:  J A Hickling; I Nazareth; S Rogers
Journal:  Br J Gen Pract       Date:  2001-08       Impact factor: 5.386

Review 6.  Implications of recent heart failure trials for patients with hypertension.

Authors:  P A Poole-Wilson
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

Review 7.  Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

Authors:  R S McKelvie; C R Benedict; S Yusuf
Journal:  BMJ       Date:  1999-05-22

Review 8.  The role of brain natriuretic peptide in population screening.

Authors:  Liselotte N Dyrbye; Margaret M Redfield
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

Review 9.  Unmet need for diagnosis of heart failure: the view from primary care.

Authors:  F D R Hobbs
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

10.  Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study.

Authors:  A M A Shehab; R J MacFadyen; M McLaren; R Tavendale; J J F Belch; A D Struthers
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.